Determining useful predictors for management decisions in basal cell carcinoma - 21/04/16
Benjamin Rostami, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States; Scott Worswick, MD, Division of Dermatology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States; Chandra Smart, MD, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, United States; Nicholas Jackson, MPH, Department of Medicine Statistics Core, David Geffen School of Medicine, UCLA, Los Angeles, CA, United States; Carolyn Goh, MD, Division of Dermatology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States
Il testo completo di questo articolo è disponibile in PDF.| Commercial support: None identified. |
Vol 74 - N° 5S1
P. AB195 - maggio 2016 Ritorno al numero
Articolo precedente
- Description and approach to a rare case of linear pigmented basal cell carcinoma
- Development of squamous cell carcinoma on actinic keratosis after ingenol mebutate (Picato@) gel
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?